A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes (GATOR)

July 18, 2016 updated by: Banyan Biomarkers, Inc

A Prospective Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes

The purpose of this study is to study the biomarkers in subjects before and after sports-induced traumatic brain injury. The assay will be studied in a sample population of subjects over the age of 18 participating in college sports.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Concussion or mild traumatic brain injury (mTBI) is a condition that affects hundreds of thousands of patients worldwide. It is a biomechanically induced neurological injury, resulting in an alteration of mental status, such as confusion or amnesia, which may or may not involve a loss of consciousness. Concussion affects about 1.6 million to 3.8 million athletes yearly, most commonly in contact sports such as American football and boxing. Early clinical effects of concussion include but are not limited to behavioral changes, impairments of memory and attention, headache, unsteadiness, and rarely, catastrophic severe brain injury (sometimes described as second impact syndrome). More recently, the consequences of repetitive mTBI from multiple concussions in a sports setting are becoming evident. Repeated concussions have been associated with greater severity of symptoms, with longer recovery time, and chronically with earlier onset of age-related memory disturbances and dementia. As a result and in contradistinction to the decades-earlier perception that these injuries were benign, sports medicine professionals are now increasingly being instructed to recognize and manage concussions as soon as they occur. "Understanding the neurobiology of concussion will lead to development and validation of physiological biomarkers of this common injury." These biomarkers (e.g., laboratory tests, imaging, electrophysiology) will then allow for improved detection, better functional assessment and evidence-based return to play recommendations.

Study Type

Observational

Enrollment (Actual)

265

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Gainesville, Florida, United States, 32610
        • University of Florida

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study will enroll athletes at the University of Florida, Gainesville. Teams considered for inclusion in the study are men's football, women's lacrosse and women's soccer.

Description

Inclusion Criteria:

  • The subject is a University of Florida student athlete on a team participating in the study
  • The Subject is at least 18 years of age at screening (has had their 18th birthday)
  • The Subject is willing to undergo the Informed Consent process prior to enrollment into this study.
  • It is the Principal Investigator's opinion that based on the knowledge of the Subject that the Subject is an appropriate candidate for the study.

Exclusion Criteria:

  • Participating in another clinical study that may affect the results of either study.
  • Venipuncture not feasible (i.e. skin integrity compromised at the venipuncture sites, blood vessel calcification.
  • Not available for the end of season follow-up visit.
  • The Subject is otherwise determined by the Investigator to be medically unsuitable for participation in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Sports induced concussion
Exposure to sports induced concussion
Biomarkers to detect specific proteins.
Routine Athletic Exertion
Exposure to routine athletic exertion (non-concussion control)
Biomarkers to detect specific proteins.
Other Non-Penetrating Trauma to the Head
Exposure to other non-penetrating trauma to the head that is witnessed or self-reported
Biomarkers to detect specific proteins.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in levels of TBI biomarkers from baseline
Time Frame: 36 months
36 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Association of TBI biomarker levels and the Post-Concussion Scale
Time Frame: 36 months
36 months
Association of TBI biomarker levels and the Standardized Assessment of Concussion
Time Frame: Baseline (beginning of Sports season), Active Phase (during Sports Season) and End of Sports Season
Baseline (beginning of Sports season), Active Phase (during Sports Season) and End of Sports Season
Association of TBI biomarker levels and the Balance Error Scoring System
Time Frame: 36 months
36 months
Safety
Time Frame: Throughout Participation in Study
The safety endpoints include the cumulative procedure-related adverse event-free survival, and cumulative unanticipated procedure-related adverse events. The only potential risks to patients in this study are those that are normally related to routine blood collection.
Throughout Participation in Study
Assessment of pituitary status and determination of the presence of autoantibodies.
Time Frame: 36 months
36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jay Clugston, MD, University of Florida

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2011

Primary Completion (ACTUAL)

July 1, 2015

Study Completion (ACTUAL)

July 1, 2015

Study Registration Dates

First Submitted

September 7, 2011

First Submitted That Met QC Criteria

November 11, 2011

First Posted (ESTIMATE)

November 16, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

July 20, 2016

Last Update Submitted That Met QC Criteria

July 18, 2016

Last Verified

July 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Traumatic Brain Injury

Clinical Trials on Banyan Biomarkers

3
Subscribe